Riskpilot← Back to searchSign inGet full accessRes non verba AB
ABActiveOrg 5568556244Vintervägen 35Medical specialists activities · NACE 8622Est. 20112 employees
Revenue 2025
SEK 1,1M
-30% vs 2024
EBITDA margin
-30.1%
-242% vs 2024
Equity ratio
93.7%
Financial strength
Net profit 2025
SEK -337K
-175% vs 2024
| Revenue | SEK 1,1M | -30% |
| EBITDA | SEK -318K | -242% |
| Net profit | SEK -337K | -175% |
| Total assets | SEK 1,5M | -33% |
| Equity | SEK 1,4M | -35% |
| Employees | 2 | — |
Legal name
Res non verba AB
Org number
5568556244
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
13 juni 2011
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva medicinsk konsultverksamhet och utöva sjukgymnastik. Bolaget ska även bedriva forskning, undervisning och utvecklingsarbete inom medicin och sjukgymnastik samt idka därmed förenlig verksamhet.
Address
Vintervägen 35
Email
evabzatterstrom@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 579 | 1 994 | 2 023 | 1 512 | 1 058 |
| Staff expenses | — | −943 | −979 | −1 010 | −1 049 |
| EBITDA | 1 355 | 706 | 707 | 225 | −318 |
| Depreciation & amort. | −27 | −30 | −30 | −30 | −30 |
| EBIT | 1 328 | 676 | 677 | 195 | −348 |
| Net financials | −1 | −2 | 24 | 42 | 11 |
| Profit before tax | 988 | 888 | 1 033 | 575 | −337 |
| Tax | −217 | −192 | −223 | −125 | — |
| Net profit | 771 | 695 | 810 | 450 | −337 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 510 | 2 745 | 2 589 | 2 224 | 1 486 |
| Equity | 1 274 | 1 770 | 2 130 | 2 129 | 1 392 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 351 | 305 | 121 | 95 | 94 |
| Total debt | 351 | 305 | 121 | 95 | 94 |
EBITDA margin
-30.1%
This company
15.8%
Market median
-291% vs market
20212025
Equity ratio
93.7%
This company
38.2%
Market median
+145% vs market
20212025
Return on equity
-24.2%
This company
18.4%
Market median
-232% vs market
20212025
Net profit margin
-31.9%
This company
8.1%
Market median
-494% vs market
20212025
Asset turnover
0.71×
This company
1.12×
Market median
-37% vs market
20212025
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Res non verba AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Astrid Eva Borelius Zätterström | Board of Directors | 0 companies |
| Ulf Kaare Zätterström | Deputy Board Member | 0 companies |